Search results for "Abietanes"

showing 3 items of 13 documents

Cytotoxicity of abietane diterpenoids from Salvia multicaulis towards multidrug-resistant cancer cells.

2018

Diterpenoids salvimulticanol (1) and salvimulticaoic acid (2) together with known diterpenoid (3-6) were isolated from Salvia multicaulis. Structures were elucidated by spectroscopic techniques including HRESIMS as well as 1D-, and 2D-NMR. In-vitro cytotoxicity was assayed against human cancer cell lines. As several metabolites exhibited activity against drug-resistance lines, compounds were screened against a panel of human drug-sensitive and multidrug-resistant cancer lines. A proposed biosynthetic pathway for these new diterpenoids (1-2) as well as the cytotoxic structure-activity relationship of all identified compounds were discussed. Compound 1 and 6 showed the most potent cytotoxicit…

Phytochemicals01 natural scienceschemistry.chemical_compoundCell Line TumorDrug DiscoverymedicineCytotoxic T cellHumansSalviaCytotoxicityAbietanePharmacologybiologyMolecular Structure010405 organic chemistryChemistryCancerGeneral MedicinePlant Components Aerialbiology.organism_classificationmedicine.diseaseDrug Resistance Multiple0104 chemical sciencesMultiple drug resistance010404 medicinal & biomolecular chemistryCell cultureDrug Resistance NeoplasmCancer cellAbietanesCancer researchEgyptSalvia multicaulisFitoterapia
researchProduct

Antimalarial activity of abietane ferruginol analogues possessing a phthalimide group.

2014

The abietane-type diterpenoid (+)-ferruginol, a bioactive compound isolated from New Zealand’s Miro tree (Podocarpus ferruginea), displays relevant pharmacological properties, including antimicrobial, cardioprotective, anti-oxidative, anti-plasmodial, leishmanicidal, anti-ulcerogenic, anti-inflammatory and anticancer. Herein, we demonstrate that ferruginol (1) and some phthalimide containing analogues 2–12 have potential antimalarial activity. The compounds were evaluated against malaria strains 3D7 and K1, and cytotoxicity was measured against a mammalian cell line panel. A promising lead, compound 3, showed potent activity with an EC50 = 86 nM (3D7 strain), 201 nM (K1 strain) and low cyto…

StereochemistryClinical BiochemistryPlasmodium falciparumPharmaceutical SciencePhthalimidesCHO CellsBiochemistryPhthalimidechemistry.chemical_compoundAntimalarialsCricetulusCricetinaeDrug DiscoveryAnimalsHumansCytotoxicityMolecular BiologyAbietaneChemistryPlant ExtractsOrganic ChemistryHep G2 CellsAntimicrobialTerpenoidBioactive compoundFerruginolAbietanesMolecular MedicineDiterpeneBioorganicmedicinal chemistry letters
researchProduct

(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.

2015

Breast cancer remains the leading cause of cancer-related death among women. The invasive triple-negative subtype is unresponsive to estrogen therapy, and few effective treatments are available. In search of new chemical scaffolds to target this disease, we conducted a phenotypic screen against the human breast carcinoma cell lines MDA-MB-231, MA11, and MCF-7 using terrestrial natural products. Natural products that preferentially inhibited proliferation of triple-negative MDA-MB-231 cells over estrogen receptor-positive cells were further studied; herein we focused on the abietanes. The activity of the abietane carnosol prompted us to generate a focus library from the readily available (+)…

medicine.drug_classPhenotypic screeningApoptosisTriple Negative Breast NeoplasmsPharmacologyCarnosolchemistry.chemical_compoundStructure-Activity RelationshipBreast cancerCell Line TumorDrug DiscoverymedicineHumansTriple-negative breast cancerCell ProliferationPharmacologyBiological ProductsDose-Response Relationship DrugMolecular StructureCell growthDrug discoveryOrganic ChemistryStereoisomerismGeneral MedicineTriple Negative Breast Neoplasmsmedicine.diseaseAntineoplastic Agents PhytogenicchemistryEstrogenAbietanesMCF-7 CellsFemaleDrug Screening Assays AntitumorEuropean journal of medicinal chemistry
researchProduct